跳至主要内容
临床试验/IRCT201402113449N14
IRCT201402113449N14已完成2 期

Comparing effects of low dose heparin as intermittent SC injection and continuous IV infusion on the serum biomarkers of thrombosis in critically ill patients

Vice Chancellor for Research, Tehran University of Medical Sciences0 个研究点目标入组 46 人开始时间: 待定最近更新:
适应症

试验速览

阶段
2 期
状态
已完成
发起方
入组人数
46

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional

入排标准

年龄范围
18 years 至 65 years(—)
性别
All

入选标准

  • Critically ill patients with age between 18-65 years old who will be admitted to ICU and have indication for deep vein thrombosis (DVT) prophylaxis
  • Exclusion criteria:
  • Patients who need DVT or pulmonary emboli treatment, have heparin contraindications, autoimmune diseases, history of acute myocardial infarction in last 21 days, and dialysis.

排除标准

  • 未提供

研究者

发起方
Vice Chancellor for Research, Tehran University of Medical Sciences

相似试验

Heparin and deep vein thrombosis | 临床试验